Biotech

All Articles

Novartis pens $150M in advance bispecifics handle Dren Bio

.Novartis has actually had some rotten luck with bispecific antitoxins before, however determining b...

AstraZeneca plants an EGFR plant with Pinetree offer worth $45M

.Pinetree Rehabs will definitely assist AstraZeneca vegetation some plants in its pipe along with a ...

GRO gathers $60M collection B to take gout therapy in to medical clinic

.GRO Biosciences has ended the week along with an additional $60.3 thousand in the financial institu...

Chutes &amp Ladders-- Gilead's Merdad Parsey goes, Cassava sheds chief executive officer

.Welcome to today's Chutes &amp Ladders, our summary of significant leadership hirings, firings and ...